Skip to main content
. 2016 Apr 29;124(12):1830–1839. doi: 10.1289/EHP212

Table 2.

Systemic effects of CAP exposure for 9 days (Study III).

Parameter, unit, n Air CAP p Air + HFD CAP + HFD p
Body weight, g, 14 27.43 ± 0.46 28.52 ± 0.61 0.163 29.36 ± 0.48 30.67 ± 0.40 0.046
Glucose, mg/dL, 14 160 ± 9 156 ± 7 0.700 167 ± 9 160 ± 6 0.489
Insulin, ng/mL, 4 0.46 ± 0.07 0.47 ± 0.06 0.898 0.85 ± 0.12 0.77 ± 0.13 0.653
HOMA-IR, 4 4.9 ± 1.0 4.5 ± 0.5 0.689 8.4 ± 0.5 8.5 ± 1.6 0.949
HOMA-β (%), 4 42.6 ± 4.8 48.4 ± 8.5 0.578 62.6 ± 6.0 73.1 ± 11.0 0.434
Adiponectin, ng/mL, 4 9.79 ± 1.90 7.02 ± 0.14 0.197 11.16 ± 2.62 13.17 ± 2.62 0.600
Leptin, ng/mL, 4 0.44 ± 0.05 0.50 ± 0.09 0.586 0.98 ± 0.33 0.84 ± 0.18 0.727
Resistin, ng/mL, 4 1.90 ± 0.87 1.92 ± 0.41 0.983 2.96 ± 1.20 2.33 ± 0.51 0.690
TNF-α, pg/mL, 4 4.53 ± 0.44 4.80 ± 1.33 0.851 4.11 ± 0.64 2.94 ± 0.47 0.212
IL-6, pg/mL, 4 8.41 ± 2.45 4.28 ± 1.25 0.184 8.45 ± 1.25 8.45 ± 1.13 0.999
TG, mg/dL, 9–10 33.56 ± 5.13 37.69 ± 4.96 0.571 16.80 ± 1.79 18.29 ± 2.51 0.634
Cholesterol, mg/dL, 9–10 66.07 ± 3.79 75.94 ± 6.55 0.222 110.41 ± 3.62 121.60 ± 6.19 0.136
HDL, mg/dL, 9–10 45.44 ± 1.96 50.81 ± 3.08 0.170 82.56 ± 2.51 93.70 ± 6.53 0.128
LDL, mg/dL, 9–10 10.38 ± 0.44 12.54 ± 1.11 0.100 18.62 ± 1.35 16.69 ± 0.61 0.210
HDL:LDL, 9–10 4.42 ± 0.21 4.16 ± 0.18 0.358 4.62 ± 0.31 5.78 ± 0.32 0.019
TP, g/dL, 9–10 4.32 ± 0.12 4.58 ± 0.15 0.198 4.33 ± 0.11 4.39 ± 0.08 0.670
Albumin, g/dL, 9–10 3.13 ± 0.07 3.25 ± 0.09 0.297 2.88 ± 0.06 2.93 ± 0.05 0.511
Albumin: TP, 9–10 0.73 ± 0.01 0.71 ± 0.01 0.242 0.67 ± 0.01 0.67 ± 0.01 0.818
ALT, U/L, 9–10 19.98 ± 1.00 26.36 ± 3.16 0.084 20.14 ± 1.94 17.59 ± 1.01 0.260
AST, U/L, 9–10 42.02 ± 4.11 51.08 ± 4.13 0.140 54.78 ± 2.96 53.99 ± 3.25 0.856
CK, U/L, 8–10 135.58 ± 16.99 132.64 ± 18.01 0.909 184.11 ± 29.64 183.60 ± 28.47 0.991
Notes: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CAP, concentrated fine particulate matter; CK, creatinine kinase; HDL, high-density lipoprotein cholesterol; HOMA-β (= 20 × fasting plasma insulin levels [mU/L]/fasting blood glucose [mmol/L] – 3.5), %; HOMA-IR (= fasting blood glucose [mmol/L] × fasting plasma insulin levels [mU/L]/22.5); IL-6, interleukin 6; LDL, low-density lipoprotein cholesterol; TG, triglycerides; TNF-α, tumor necrosis factor α; TP, total protein. Blood and plasma parameters were measured in control or high-fat diet (HFD)-fed mice exposed for 30 days to air or CAP. Data represent the mean ± SE; p, air versus CAP.